Genetron Health Announces Publication of Enhanced Variant Caller Performance Data in Briefings in Bioinformatics
November 15, 2021 05:00 ET
|
Genetron Holdings Limited
BEIJING, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Establishes Strategic Partnership with NeoGenomics to Drive Global Oncology Drug Research and Development
November 08, 2021 05:00 ET
|
Genetron Holdings Limited
BEIJING, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health to Announce Third Quarter 2021 Financial Results and Host Investor Call on November 30, 2021
November 04, 2021 16:05 ET
|
Genetron Holdings Limited
BEIJING, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health’s Multi-Gene Mutation Detection Kit Onco PanScan™ Obtains CE Mark
November 04, 2021 06:00 ET
|
Genetron Holdings Limited
BEIJING, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering...
Genetron Health Wins Second Prize of China’s National Science and Technology Progress Award for Contributions to Lung Cancer Precision Medicine Project
November 03, 2021 02:00 ET
|
Genetron Holdings Limited
BEIJING, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering...
Genetron Health’s Liver Cancer Screening Results and Technology Findings Included in the Chinese Journal of Hepatology
October 28, 2021 00:38 ET
|
Genetron Holdings Limited
BEIJING, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering...
Genetron Health and Fosun Pharma Announce Exclusive Partnership to Commercialize Seq-MRD® in China
October 22, 2021 07:00 ET
|
Genetron Holdings Limited
SHANGHAI, China, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that...
Genetron Health and IMPACT Therapeutics Announce Partnership to Drive Development of Synthetic Lethal Product Pipeline
September 27, 2021 06:00 ET
|
Genetron Holdings Limited
BEIJING, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Unveils 13 Cancer Research findings at ESMO Congress 2021
September 16, 2021 06:00 ET
|
Genetron Holdings Limited
BEIJING, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Added to FTSE Russell Global Equity Index Series
September 03, 2021 11:07 ET
|
Genetron Holdings Limited
BEIJING, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), today announced that Genetron will be added to the below FTSE Global Equity...